Overview

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are: - To assess the effect of ophthalmic phentolamine mesylate in mesopic conditions on the four endpoints: 1. Contrast sensitivity 2. Low contrast visual acuity 3. Wavefront aberrometry 4. Subjective questionnaire - To assess the safety of ophthalmic phentolamine mesylate
Phase:
Phase 2
Details
Lead Sponsor:
Ocuphire Pharma, Inc.
Collaborator:
Ophthalmic Consultants of Long Island
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions
Phentolamine